Pfizer Net Income 2012-2026 | PFE

Pfizer net income for the twelve months ending March 31, 2026 was $7.490B, a 4.99% decline year-over-year.

  • Pfizer annual net income for 2025 was $7.771B, a 3.24% decline from 2024.
  • Pfizer annual net income for 2024 was $8.031B, a 279% increase from 2023.
  • Pfizer annual net income for 2023 was $2.119B, a 93.25% decline from 2022.

Pfizer Net Income 2012-2026 | PFE

  • Pfizer annual net income for 2025 was $7.771B, a 3.24% decline from 2024.
  • Pfizer annual net income for 2024 was $8.031B, a 279% increase from 2023.
  • Pfizer annual net income for 2023 was $2.119B, a 93.25% decline from 2022.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B